Compare OVID & PDEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OVID | PDEX |
|---|---|---|
| Founded | 2014 | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.8M | 106.5M |
| IPO Year | 2017 | N/A |
| Metric | OVID | PDEX |
|---|---|---|
| Price | $1.67 | $37.84 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | $3.50 | ★ $56.00 |
| AVG Volume (30 Days) | ★ 1.5M | 31.4K |
| Earning Date | 11-12-2025 | 01-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 122.94 |
| EPS | N/A | ★ 3.31 |
| Revenue | $6,610,000.00 | ★ $70,231,000.00 |
| Revenue This Year | $1,077.56 | $7.22 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $11.61 |
| Revenue Growth | ★ 945.89 | 23.65 |
| 52 Week Low | $0.24 | $23.47 |
| 52 Week High | $2.01 | $70.26 |
| Indicator | OVID | PDEX |
|---|---|---|
| Relative Strength Index (RSI) | 54.00 | 44.67 |
| Support Level | $1.59 | $38.13 |
| Resistance Level | $1.88 | $43.30 |
| Average True Range (ATR) | 0.12 | 2.74 |
| MACD | -0.00 | -0.85 |
| Stochastic Oscillator | 66.13 | 0.66 |
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries. Its product portfolio includes autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers used mainly in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, regulatory consulting services, and manufactures rotary air motors utilized in various industries. Operating out of ISO-certified facilities in California, Pro-Dex serves hospitals, medical labs, and high-tech manufacturers, generating revenue through sales of surgical instruments and related services.